2024/2/4 17:07:46
Anglikang Pharmaceutical and Affinity Biopharma Reached Strategic Cooperation Agreement
News
-
-
2022/8/9 11:19:32Affinity QHL-236 Legutaxel Clinical Trial Granted Approval in Australia
-
2022/4/20 14:59:47Affinity QHL-236 Legutaxel Clinical Trial Application Granted Implied Permission
-
2022/2/24 11:23:56Affinity Announces Dosing of First Patient in Phase II/III Clinical Trial in QHL-108 Project
-
2021/12/8 13:33:27Affinity Completes the Dose Escalation Study in QHL-108 Phase 1 Trial
-
2021/11/1 13:31:52Affinity Successfully Holds the QHL-108 1b2a Expansion Trial Kick-off Meeting
-
2021/9/18 11:46:51Affinity Successfully Holds the QHL-108 Phase II/III Clinical Trial National Kick-off Meeting in Beijing